Flignitz PharmaCorp is proud to announce that our breakthrough drug Aggravil™ is now available in easy-to-swallow 200mg capsules.
Aggravil™ (diphosgermine sulfate) is a pain reliever and atypical hypnotic sedative, used to treat moderate-to-severe pain and psychological disturbances, common symptoms of GSD in adults, adolescents, and children age 6 and older.
Aggravil™ oral formulations are specifically indicated for:
- Moderate-to-severe pain (including psychosomatic pain often associated with imagined injuries, emotional discomfort, and perceived slight/disrespect in certain social situations)
- General satisfaction disorder (GSD, as diagnosed by criteria established in DSM-V)
- Adjunct therapy for persistent and otherwise untreatable allergic reactions, emotional trauma, indignation, toe fungus, and a variety of mysterious and undiagnosable syndromes, complexes, and maladies.
CAUTION: Take Aggravil™ only as directed by your doctor. Do not skip a dose or take more Aggravil™ than directed, no matter how good it seems to make you feel.
For complete drug information on dosing, side effects, and indications, please refer to official Aggravil™ product information for patients and doctors, provided by Flignitz PharmaCorp Ltd.
Download our current Aggravil™ product overview.
Copyright © 2015 Flignitz PharmaCorp Ltd.
All rights reserved.